Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Prestige Consumer Healthcare (PBH) over the last 17 years, with Q4 2025 value amounting to $0.97.

  • Prestige Consumer Healthcare's EPS (Weighted Average and Diluted) fell 2049.18% to $0.97 in Q4 2025 from the same period last year, while for Dec 2025 it was $3.79, marking a year-over-year decrease of 1124.12%. This contributed to the annual value of $4.29 for FY2025, which is 276.36% up from last year.
  • Per Prestige Consumer Healthcare's latest filing, its EPS (Weighted Average and Diluted) stood at $0.97 for Q4 2025, which was down 2049.18% from $0.86 recorded in Q3 2025.
  • In the past 5 years, Prestige Consumer Healthcare's EPS (Weighted Average and Diluted) registered a high of $1.22 during Q4 2024, and its lowest value of -$4.79 during Q1 2023.
  • For the 5-year period, Prestige Consumer Healthcare's EPS (Weighted Average and Diluted) averaged around $0.72, with its median value being $1.01 (2022).
  • As far as peak fluctuations go, Prestige Consumer Healthcare's EPS (Weighted Average and Diluted) tumbled by 56960.78% in 2023, and later surged by 12045.93% in 2024.
  • Over the past 5 years, Prestige Consumer Healthcare's EPS (Weighted Average and Diluted) (Quarter) stood at $0.99 in 2021, then increased by 5.05% to $1.04 in 2022, then grew by 1.92% to $1.06 in 2023, then rose by 15.09% to $1.22 in 2024, then decreased by 20.49% to $0.97 in 2025.
  • Its EPS (Weighted Average and Diluted) was $0.97 in Q4 2025, compared to $0.86 in Q3 2025 and $0.95 in Q2 2025.